nbmr1,

I think there are politics involved a number of levels and will leave it at that. You are 100% correct that competition in an open rather than hyper- regulated market changes the calculus.

I believe that Cytodyn will emerge from beneath the wet blanket the FDA has thrown and that doctors and patients will have the final say. I am disappointed but in no way discouraged about the prospects for Leronlimab, Cytodyn and us investors.